BRAF NP_004324.2:p.V600E
2 clinical trials · Condition
◉ Watch BRAF NP_004324.2:p.V600E
| Record | Firm | Date |
|---|---|---|
| Dabrafenib, Trametinib, and IMRT in Treating Patients With BRAF Mutated Anaplastic Thyroid Cancer (NCT03975231) | City of Hope Medical Center | 2020-09-14 |
| Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal Cancer (NCT04017650) | M.D. Anderson Cancer Center | 2019-06-14 |
Track BRAF NP_004324.2:p.V600E automatically
Every clearance here is in the API, with alerts when new ones post.